Corden Pharma GmbH (responsible for manufacturing "in bulk", quality control)

The drug is prescribed for the treatment of patients with locally advanced prostate cancer (without metastases) in cases of high risk of disease progression. It may be used as monotherapy or as an adjunct to surgical intervention or radiotherapy.

Dosage form: tablets, film-coated

ATC: L02BB03